This topic contains a solution. Click here to go to the answer

Author Question: For a within-subjects study comparing two treatments, A and B, a researcher expects that practice in ... (Read 123 times)

elizabeth18

  • Hero Member
  • *****
  • Posts: 559
For a within-subjects study comparing two treatments, A and B, a researcher expects that practice in the first treatment will improve the participants' scores in the second treatment. If the order of treatments is counterbalanced, then the practice will ____.
 
  a. influence scores in treatment A, but not in treatment B
 b. influence scores in treatment B, but not in treatment A
 c. influence scores in treatment A for half the participants and scores in treatment B for half the participants
  d. not influence the scores in either treatment condition because the treatments are counterbalanced

Question 2

A yes-no question represents a(n) ____ response.
 
  a. interval response
  b. nominal
  c. multiple response
  d. ratio



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

c

Answer to Question 2

a





 

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

For a complete list of videos, visit our video library